If you liked this article you might like

Medivation Scores Premium in Sale to Pfizer
Why Allergan is Fine Without Large M&A
Glaucoma Treatment Maker a $95M
Why Hendrickson-Led Perrigo Is A Good Bet For Long Term Investors